mRNA Covid 19 - Search News

New mRNA flu vaccine faces scrutiny

FDA panel backs first-of-its-kind flu vaccine using mRNA technology

The Food and Drug Administration is evaluating Moderna’s new shot, dubbed mFlusiva, for older Americans ahead of the winter flu season. Moderna is seeking full approval for the vaccine’s use in people ages 50 to 64 — along with authorization for use in those 65 and older while it conducts additional testing.

· 1d

Future flu seasons may look different thanks to mRNA technology. Find out why.

· 1d

Moderna's mRNA flu vaccine backed by FDA advisers

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

Invivyd expects to report topline data from LIBERTY in Q3 2026Data from LIBERTY can provide important insight into the VYD2311 clinical profile ...

Forbes

How mRNA Vaccine Platform Suffers Mainly From Manufactured Distrust

WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently ...

mRNA treatments could help stop cancer recurrence: Study

Researchers are particularly encouraged by new data involving a personalized mRNA therapy developed by Moderna and Merck.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results